Document is current
Any future updates will be listed below
-
Authors
Lu, Yafei
Huangfu, Shaohua
Ma, Chuanxue
Ding, Yan
Zhang, Yajie
Zhou, Chungen
Liao, Lianming
Li, Ming
You, Jia
Chen, Yuting
Wang, Dawei
Chen, Ao
Jiang, Bin https://orcid.org/0000-0002-4622-9703
-
Funding
Funding for this research was provided by:
General Program of Jiangsu Province Social Development-oriented Special Fund Project (BE2022674)
National Natural Science Foundation of China (No. 82004365)
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 28 October 2024
First Online: 29 December 2024
Declarations
:
: This study received approval from the Ethics Committee of Nanjing University of Chinese Medicine on July 3, 2023 (Project name: Mechanism of Treating Complex Perianal Fistulas by Regulating the Hif-1α Signaling Pathway with Sijunzi Decoction Combined with Umbilical Mesenchymal Stem Cell Exosomes. Ethics Approval Number: A230606). This research strictly adhered to the standards for the use of experimental animals set by the National Institutes of Health of China. The MSCs used in this study were all produced and supplied by the Jiangsu Topcel-KH Pharmaceutical Co., Ltd (Jiangsu Provincial Cell Center) (Approval Number: 20230523-k130). Written informed consent was obtained from all study participants.
: All authors confirm their consent for publication.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
